Education
Academic Background-
Ph.D. Aristotle University of Thessaloniki, Greece Helicobacter Pylori Infection | Completed: 2011
Publications (39)
Selected Scholarly Contributions
Anemia in a Cohort of Greek Patients with Sickle Cell Disease: Clinical Insights and Therapeutic Challenges
2026
Phase 2a randomized study to evaluate sapablursen in patients with non-transfusion dependent β-thalassemia intermedia
2026
Pilot of the International Hemoglobinopathy Research Network for a multiethnic genome-wide association study
2026
Comparative analysis of mortality patterns and treatment strategies in thalassaemia and sickle cell disease patients: A 12‐year study
2025
Splenectomy and complications: A complex different disease background, yet a common denominator exists
2025
NPM1-Mutated AML: Deciphering the Molecular and Clinical Puzzle in the Era of Novel Treatment Strategies
2025
Myeloid Sarcoma: Novel Advances Regarding Molecular Pathogenesis, Presentation and Therapeutic Options
2024
Clinical significance of mutational variants in beta and alpha genes in patients with hemoglobinopathies from two large Greek centers: a complex interplay between genotype and phenotype
2023
Concomitant Presence of Hb Agrinio and - -Med Deletion in a Greek Male Patient with Hemoglobinopathy H: More Severe Phenotype and Literature Review
2023
2016
Myelodysplastic syndromes: Aiming at deciphering their secrets.
Michael D. Diamantidis
2016
Iron chelation therapy of transfusion-dependent β-thalassemia during pregnancy in the era of novel drugs: Is deferasirox toxic?
Michael D. Diamantidis
2016
The presence of low-count chronic lymphocytic leukemia-like monoclonal B lymphocytosis in patients with Ph-myeloproliferative neoplasms: A random event or a shared causal pathobiology?
Michael D. Diamantidis
2015
Toward adjunctive therapy of acute myeloid leukemia: Is it feasible?
Michael D. Diamantidis
2014
Alpha heavy chain disease: A frequently fatal rare lymphoma hard to diagnose.
Michael D. Diamantidis
2014
Concurrent presentation of nodal myeloid sarcoma and bone marrow chronic lymphocytic leukemia/small lymphocytic lymphoma: A unique association.
Michael D. Diamantidis
2014
Supplementary information regarding Helicobacter pylori, concomitant infections, lymphomagenesis and cardiovascular disease.
Michael D. Diamantidis
2014
The role of Helicobacter pylori infection in hematological disorders.
Michael D. Diamantidis
2013
Long-term outcome of primary endocrine non-Hodgkin lymphomas: Does the site make the difference?
Michael D. Diamantidis
2013
Acute vision loss revealing central nervous system aggressive myelomatosis.
Michael D. Diamantidis
2012
Copper levels in patients with haematological malignancies.
Michael D. Diamantidis
2012
Ruxolitinib for myelofibrosis.
Michael D. Diamantidis
2012
Successful treatment with Rituximab in a patient with life-threatening resistant thrombotic thrombopenic purpura.
Michael D. Diamantidis
2012
Aberrant expression of myeloid and B cell markers in an aggressive multiple-site myeloid sarcoma.
Michael D. Diamantidis
2012
Perils and pitfalls regarding differential diagnosis and treatment of primary cutaneous anaplastic large-cell lymphoma.
Michael D. Diamantidis
2011
Modern industrialisation may increase primary open-angle glaucoma prevalence through easier transmission of Helicobacter pylori infection.
Michael D. Diamantidis
2011
Is diabetes a causal agent for colorectal cancer? Pathophysiological and molecular mechanisms.
Michael D. Diamantidis
2011
Aggressive systemic mastocytosis associated with mesangioproliferative glomerulonephritis.
Michael D. Diamantidis
2011
High prevalence of Helicobacter pylori infection in Greek patients with myelodysplastic syndromes.
Michael D. Diamantidis
2010
Corynebacterium jeikeium bacteremia in a hemodialyzed patient.
Michael D. Diamantidis
2010
Differential diagnosis and treatment of primary, cutaneous, anaplastic large cell lymphoma: Not always an easy task.
Michael D. Diamantidis
2009
Novel extended reference range for serum κ/λ free light chain ratio in diagnosing monoclonal gammopathies in renal insufficient patients.
Michael D. Diamantidis
2009
A concept of helicobacter pylori and stress-secreted mast cells' potential involvement in brain metastases.
Michael D. Diamantidis
2009
Fatal chylous ascites, pericarditis and extensive venous thrombosis, due to an aggressive T cell non-Hodgkin lymphoma.
Michael D. Diamantidis
2009
Veno-occlusive disease of the liver during induction therapy for acute lymphoblastic leukemia.
Michael D. Diamantidis
2008
Increased incidence of iron deficiency anemia secondary to inadequate iron intake in institutionalized, young patients with cerebral palsy.
Michael D. Diamantidis
2008
New aspects of regulatory signaling pathways and novel therapies in pancreatic cancer.
Michael D. Diamantidis
2008
Helicobacter Pylori infection might protect from the leukaemic transformation of myelodysplastic syndromes.
Michael D. Diamantidis
2008
The role of apoptosis and current therapeutic challenges in myelodysplastic syndromes.
Michael D. Diamantidis
2007